Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0100
+0.0800 (4.15%)
NASDAQ · Last Trade: May 6th, 7:12 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors